ACRO 2026 Global Clinical Trials Regulatory Summit

About the event

ACRO, an association representing the world’s leading clinical research and technology organizations, invites you to participate in a global summit focused on the most pressing regulatory issues and opportunities impacting clinical trials and innovation. 

This summit will convene senior regulators and senior industry leaders from around the globe for frank, off-the-record exchanges as we all look to tackle and explore harmonized regulatory approaches to the extraordinary challenges – and opportunities – in drug development today. Invitees include leaders from the FDA, EMA, MHRA, Health Canada, TGA, CDSCO, NMPA, PMDA, and others.

This event will cover emerging topics like:

• Artificial Intelligence and Machine Learning
• Clinical Trial Continuity during Times of Disruption
• International Regulatory Convergence and Navigating Changes in National Contexts
• The future vision for patient-focused drug development
• Safeguarding data integrity in an increasingly complex digital and remote environment

Please don’t hesitate to contact us if you require additional information or have any questions regarding the goals and objectives of the Summit. Contact Karen Noonan at knoonan@acrohealth.org, Clay Alspach at clay.alspach@leavittpartners.com, or Victoria Gemme at Victoria.Gemme@leavittpartners.com